PRELUDE THERAPEUTICS INCORPORATED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.865 USD | -1.65% |
|
-0.76% | -7.96% |
Chart calendar Prelude Therapeutics Incorporated
2afdfb7ffa233f018afba.dKQmxueVwCfyvqzKhFSaPHbGfpqDmkGbcWe07FA81N8.N-NqvJHP-BeK0-7n1T7tTAWNSKi18nHcAxbRqGRSm4Y6nEmWrf2FZITfxw~d21057224dc797b0902ffae79675d8bc
Upcoming events on Prelude Therapeutics Incorporated
Past events on Prelude Therapeutics Incorporated
| 14/06/2024 09:00 pm | Annual General Meeting |
| 12/06/2024 08:10 pm | Goldman Sachs Global Healthcare Conference |
| 06/06/2024 11:00 pm | Jefferies Global Healthcare Conference |
| 17/05/2024 07:30 am | Investor Meeting - SMARCA |
| 14/05/2024 10:30 pm | Citizens JMP Life Sciences Conference - Fireside Chat |
| 07/05/2024 04:31 pm | Q1 2024 Earnings Release |
| 10/04/2024 02:00 am | American Association for Cancer Research Meeting - Abstract No - 5710 |
| 10/04/2024 02:00 am | American Association for Cancer Research Meeting - Abstract No - 5966 |
| 09/04/2024 09:30 pm | American Association for Cancer Research Meeting - Abstract No - 4503 |
| 06/04/2024 07:30 am | American Association for Cancer Research Meeting |
| 14/03/2024 12:35 am | Barclays Global Healthcare Conference - Fireside Chat |
| 16/02/2024 02:35 am | Q4 2023 Earnings Release |
| 02/11/2023 01:40 am | Q3 2023 Earnings Release |
| 11/10/2023 | AACR-NCI-EORTC International Conference |
| 13/09/2023 02:25 am | Morgan Stanley Global Healthcare Conference |
| 11/09/2023 11:00 pm | H.C. Wainwright Global Investment Conference |
| 07/09/2023 02:00 am | Wells Fargo Healthcare Conference |
| 03/08/2023 05:30 pm | Q2 2023 Earnings Release |
| 16/06/2023 10:30 pm | Annual General Meeting |
| 07/06/2023 05:30 pm | Jefferies Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -58,2 -58,9 1.14% | -113 -114 1.01% | -122 -119 -2.63% | -131 -131 -0.05% | -158 |
|
EBIT Million USD | Released Forecast Spread | -58,8 -59,3 0.88% | -114 -114 0.66% | -124 -120 -2.68% | -132 -131 -0.97% | -150 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -115 -120 3.64% | 0,00 0,00 - | -128 |
|
Net income Million USD | Released Forecast Spread | -56,9 -56,7 -0.49% | -112 -111 -0.2% | -115 -118 1.86% | -122 -121 -0.95% | -128 |
|
EPS USD | Released Forecast Spread | -4,56 -1,76 -159.09% | -2,43 -2,42 -0.62% | -2,44 -2,48 1.61% | -2,02 -2,02 0% | -1,66 |
| Announcement Date | 16/03/21 | 16/03/22 | 15/03/23 | 15/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -30,0 -30,7 2.43% | -29,1 -28,8 -1.36% | -30,1 -31,3 4.06% | |||||||||||
|
EBIT Million USD | Released Forecast Spread | -30,3 -30,7 1.43% | -29,5 -30,4 3.04% | -30,4 -30,7 0.84% | -33,4 -30,4 -9.67% | -29,1 -32,4 10.04% | -32,4 -30,0 -7.99% | -33,4 -33,5 0.48% | -37,4 -34,6 -8.1% | -34,3 -36,6 6.26% | -34,5 | -34,8 | -37,0 | -37,2 | -39,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -27,4 -30,6 10.54% | -30,0 -29,8 -0.53% | -28,6 -30,7 6.71% | -27,7 -29,9 7.3% | -30,4 -30,0 -1.44% | -30,6 -30,2 -1.35% | -31,4 -33,4 5.83% | -30,9 | -31,6 | -34,2 | -32,2 | -34,7 | ||
|
Net income Million USD | Released Forecast Spread | -29,5 -30,2 2.49% | -27,4 -29,9 8.6% | -30,0 -30,1 0.62% | -28,6 -30,1 4.73% | -27,7 -32,2 13.88% | -30,4 -30,0 -1.44% | -30,6 -30,6 0.08% | -33,1 -31,9 -3.6% | -31,4 -33,3 5.58% | -30,9 | -31,6 | -34,2 | -32,2 | -34,7 |
|
EPS USD | Released Forecast Spread | -0,63 -0,65 3.08% | -0,58 -0,59 1.14% | -0,63 -0,63 0.53% | -0,60 -0,63 4.76% | -0,58 -0,68 14.07% | -0,54 -0,63 14.29% | -0,45 -0,56 19.64% | -0,45 -0,47 4.26% | -0,42 -0,50 15.15% | -0,41 | -0,42 | -0,42 | -0,33 | -0,36 |
| Announcement Date | 10/05/22 | 09/08/22 | 14/11/22 | 15/03/23 | 08/05/23 | 03/08/23 | 01/11/23 | 15/02/24 | 07/05/24 | - | - | - | - | - |
| 15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 10:30 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 26/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 10:30 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Prelude Therapeutics Incorporated
| 07/06/2024 12:27 pm | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 30/05/2024 01:31 am | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 04:30 pm | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 10:30 am | EVOTEC SE: Q1 2024 Earnings Release |
| 22/05/2024 02:44 am | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PRLD Stock
- Calendar Prelude Therapeutics Incorporated
